Truveris Secures $15 Million in Series E Funding ThroughCanaan Partners and New Leaf Venture Partners New funding by existing investors will support company’s next stage of development and core business growth. Truveris, the leader in pharmacy cost containment and...
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) – After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival...
Recent Comments